How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?

Since the beginning of the Coronavirus disease (COVID)-19 pandemic in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for more than 600 million infections and 6.5 million deaths worldwide. Given the persistence of SARS-CoV-2 and its ability to dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Pons, Stéphanie, Uhel, Fabrice, Frapy, Eric, Sérémé, Youssouf, Zafrani, Lara, Aschard, Hugues, Skurnik, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685122/
https://www.ncbi.nlm.nih.gov/pubmed/36422774
http://dx.doi.org/10.1007/s12015-022-10477-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685122/
https://www.ncbi.nlm.nih.gov/pubmed/36422774
http://dx.doi.org/10.1007/s12015-022-10477-y

Ejemplares similares